The panel shall review and, to the extent resources and expertise permit, make findings on all of the following:

1. (a) The health effects of exposure to fungi, based on a review of the literature addressing immunology, infectious disease, and medical evaluation.
2. (b) The practices for assessing fungal contamination, including the use of visual inspection, surface sampling, air monitoring, and the proper analysis of environmental samples.
3. (c) To the extent feasible, the appropriateness of commercially available methods for identifying fungal contamination of building components including, but not limited to, walls, ventilation systems, and support beams.
4. (d) The options for preventing and remediating fungal contamination in indoor environments. The findings are intended as a practical guide regarding options for building managers, homeowners, and members of the general public who may have concerns about fungal contamination in living and working environments.
5. (e) Recommendations on hazard communication for distinct subpopulations, including workers employed in high-risk occupations.
6. (f) The development of a recommended reading list related to molds, their health effects, their impacts on indoor air quality, and related topics for local government officials, including environmental health officers.
7. (g) Any additional topical areas deemed appropriate by the review panel.